Intrauterine Growth Restriction
Intrauterine Growth Restriction
Intrauterine Growth Restriction
RESTRICTION
Synopsis
• Definition
• Incidence
• Classification of IUGR
• Etiology
• Pathophysiology
• Diagnosis
• Complications
• Management
DEFINITION
Maternal Causes
• Constitutional:
• Small woman
• Slim, Low BMI
1. Maternal genetic and racial predisposition.
• Maternal undernutrition
• Maternal diseases:
1. Anemia
2. PIH
3. Chronic renal disease
4. Heart disease ( NYHA class 3/4)
5. Connective tissue diseases
6. Thrombotic diseases
7. Diabetes with vasculopathy or PIH.
• Toxins: like alcohol, smoking, cocaine, heroin, drugs
ETIOLOGY
Fetal causes:
Structural anomalies
• Chromosomal anomalies: like triploidy, aneuploidy or trisomies.
Common anomalies- Trisomy 13, 18, 21 and Turner’s syndrome
Infection: like TORCH agents or Malaria
• Multiple gestation – due to mechanical hinderance to growth and excessive fetal demands.
Placental causes:
• Placental insufficiency
• Abnormal placentation: like placenta previa, abruption, circumvallate placenta, infaction and
mosaicism
• Calcifications.
Unknown: The cause for IUGR remains unknown in about 40% of cases
PATHOPHYSIOLOGY
PREDICTIVE FACTORS:
• Maternal risk factors.
• Reduced BMI
• Less weight gain during pregnancy
• Low level of 1st trimester PAPP-1 value
• Abnormal uterine artery Doppler value (notching) at 20-24 wks
• Fetal echogenic bowel on USG
DIAGNOSIS
CLINICAL FEATURES
• Lag in symphysiofundal height of 3 or more cm on serial measurement.
• Maternal weight gain remains stationary or at times falls during the 2nd
half of pregnancy
• Abdominal girth values remains stationary or falls on serial measurement.
DIAGNOSIS
ULTRASOUND FINDINGS:
• HC/AC ratio:
• Normally, as pregnancy advances AC (abdominal circumference) increases ,
so HC/AC value decreases
• In asymmetric IUGR, AC value reduces and so HC/AC value increases
• In symmetry IUGR, both HC( head circumference) and AC value is reduced ,
so HC/AC value remains normal.
• FL/AC ratio:
• Femur length(FL)/ AC ratio normally is 22 from 21 wks to term.
• FL is normal in asymmetric IUGR , AC is reduced, so FL/AC is increased
(>23.5)
• Amniotic fluid Volume:
• Single deepest vertical pocket (SDVP) <1cm suggests IUGR
• Amniotic fluid index (AFI) <5 indicates oligohydramnios
DIAGNOSIS
IMMEDIATE:
Asphyxia, bronchopulmonary dysplasia, RDS
• Hypoglycemia due to low liver glycogen
• Meconium aspiration syndrome
• Microcoagulation leading to DIC
• Hypothermia
• Pulmonary hemorrhage
• Polycythemia, Anemia, thrombocytopenia
• Hyperviscosity/ thrombosis
• Necrotising enterocolitis
• Intraventricular hemorrhage
• Electrolyte abnormalities ( low Calcium and potassium, high phosphate)
• Multiorgan failure
• Increased perinatal mortality and morbidity
COMPLICATIONS
LATE:
• Neurological retardation, intellectual disabilities
• Increased risk of metabolic syndrome in adult life
• Altered orexigenic mechanisms leading to increased appetite and reduced
satiety
• Low number of nephrons- causing renal vascular hypertension
GENERAL:
• Adequate bedrest in left lateral position
• Correct malnutrition- 300 extra kcal to be taken
• Appropriate therapy for the cause of FGR
• Avoid tobacco, alcohol.
• Maternal hyperoxygenation- 2.5L/min
• Low dose aspirin (50mg daily) if h/o thrombosis, hypertension, or recurrent IUGR present.
• Maternal volume expansion to improve placental prefusion.
MANAGEMENT
ANTEPARTUM EVALUATION:
USG: every 3-4 wks to assess BPD, HC, AC, fetal weight, AFI
• Fetal well being: kick count, NST, biophysical profile.
• Doppler ultrasound parameters
MANAGEMENT
TIMING OF DELIVERY:
Optimum time for delivering: 34-37 wks
• Pregnancy > 37wks: Delivery should be done
• Pregnancy <37 wks:
• Uncomplicated/ mild IUGR: Pregnancy continued till 37 wks , then delivery done
• Severe IUGR: delivery planned based on fetal surveillance reports.
• Delivery done if lung maturity achieved (L:S ratio >= 2)
• If lung maturity not achieved, betamethasone given if <34 wks
• If delivery should be done before 32 wks, magnesium sulphate given to mother for fetal
neuroprotection
• Fetus with aneuploidy or cong. Infections have poor outcome irrespective of gestational
age and time of delivery.
MANAGEMENT
METHODS OF DELIVERY:
• Low rupture of membranes followed by oxytocin is done when
pregnancy is beyond 34 wks with favourable cervix and head deep in
pelvis. PGE2 can be given if cervix not favourable.
• Intrapartum monitoring by clinical and blood sampling necessary to
detect Intrapartum asphyxia.
• Cesarean delivery without trial of labour done when risk of vaginal
delivery is more.
MANAGEMENT PROTOCOL FOR FGR
THANK YOU